指南与共识糖尿病

国家临床护理委员会致国会报告:更好利用联邦政策与项目以预防和控制糖尿病的建议

The National Clinical Care Commission Report to Congress: Recommendations to Better Leverage Federal Policies and Programs to Prevent and Control Diabetes.
指南 / 共识 · Diabetes Care · 2023-01-01

国家临床护理委员会(NCCC)受国会委托,综合社会生态学与慢病护理模型框架,通过调查联邦机构、召开12次公开会议、征集公众意见和文献综述,于2022年1月向国会提交最终报告,含39条具体建议,包括3条基础性建议,涉及全政府策略、健康公平和医疗可及性,并针对普通人群、2型糖尿病高危人群及糖尿病并发症患者提出政策强化、障碍消除、劳动力扩充和支付模式创新等建议。

要点

  • NCCC于2022年1月向国会提交最终报告,含39条具体建议,其中3条为基础性建议。
  • 针对普通人群,建议联邦政府采取「健康融入所有政策」策略,协调非卫生与卫生机构活动。
  • 针对2型糖尿病高危人群(含糖尿病前期),建议强化政策提高糖尿病前期意识及强化生活方式干预的可及性、转诊和保险覆盖,并汇集数据寻求批准二甲双胍用于糖尿病预防。

核心结论

  • NCCC向国会提交最终报告,含39条具体建议,包括3条基础性建议,涉及全政府策略、健康公平和医疗可及性。
  • NCCC强烈鼓励公众支持这些建议,并呼吁国会迅速采取行动。

研究设计与样本

  • NCCC由国会设立,制定整合社会生态学与慢病护理模型要素的指导框架。
  • 调查联邦机构并与10个卫生相关和11个非卫生相关联邦机构代表举行后续会议。
  • 举行12次公开会议,征集公众意见,会见众多利益相关方和关键信息提供者,并进行全面文献综述。
  • 最终报告于2022年1月传送至国会。

主要发现

  • 最终报告含39条具体建议,其中3条基础性建议涉及全政府策略、健康公平和医疗可及性。
  • 针对普通人群,建议联邦政府采取「健康融入所有政策」策略,协调农业、食品、住房、交通、商业和环境等非卫生相关联邦机构活动与卫生相关联邦机构活动,以积极应对导致糖尿病及其并发症的社会和环境条件。
  • 针对2型糖尿病高危人群(含糖尿病前期),建议强化联邦政策与项目,提高糖尿病前期意识及强化生活方式干预的可及性、转诊和保险覆盖,并汇集数据寻求批准二甲双胍用于糖尿病预防。
  • 针对糖尿病患者及并发症,建议消除有效治疗的障碍、增加治疗劳动力规模和能力、实施新支付模式以支持获得救命药物和有效治疗。
  • NCCC还概述了雄心勃勃的研究议程。

关键数值与推荐

  • 最终报告含39条具体建议,包括3条基础性建议,涉及全政府策略、健康公平和医疗可及性。
  • 针对普通人群,建议联邦政府采取「健康融入所有政策」策略,协调非卫生与卫生相关联邦机构活动。
  • 针对2型糖尿病高危人群(含糖尿病前期),建议强化联邦政策与项目,提高糖尿病前期意识及强化生活方式干预的可及性、转诊和保险覆盖,并汇集数据寻求批准二甲双胍用于糖尿病预防。
  • 针对糖尿病患者及并发症,建议消除有效治疗的障碍、增加劳动力规模和能力、实施新支付模式以支持获得救命药物和有效治疗。

临床怎么用

  • NCCC强烈鼓励公众支持这些建议,并呼吁国会迅速采取行动。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The National Clinical Care Commission (NCCC) was established by Congress to make recommendations to leverage federal policies and programs to more effectively prevent and treat diabetes and its complications. The NCCC developed a guiding framework that incorporated elements of the Socioecological and Chronic Care Models. It surveyed federal agencies and conducted follow-up meetings with representatives from 10 health-related and 11 non-health-related federal agencies. It held 12 public meetings, solicited public comments, met with numerous interested parties and key informants, and performed comprehensive literature reviews. The final report, transmitted to Congress in January 2022, contained 39 specific recommendations, including 3 foundational recommendations that addressed the necessity of an all-of-government approach to diabetes, health equity, and access to health care. At the general population level, the NCCC recommended that the federal government adopt a health-in-all-policies approach so that the activities of non-health-related federal agencies that address agriculture, food, housing, transportation, commerce, and the environment be coordinated with those of health-related federal agencies to affirmatively address the social and environmental conditions that contribute to diabetes and its complications. For individuals at risk for type 2 diabetes, including those with prediabetes, the NCCC recommended that federal policies and programs be strengthened to increase awareness of prediabetes and the availability of, referral to, and insurance coverage for intensive lifestyle interventions for diabetes prevention and that data be assembled to seek approval of metformin for diabetes prevention. For people with diabetes and its complications, the NCCC recommended that barriers to proven effective treatments for diabetes and its complications be removed, the size and competence of the workforce to treat diabetes and its complications be increased, and new payment models be implemented to support access to lifesaving medications and proven effective treatments for diabetes and its complications. The NCCC also outlined an ambitious research agenda. The NCCC strongly encourages the public to support these recommendations and Congress to take swift action.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Herman WH, Schillinger D, Bolen S, et al. The National Clinical Care Commission Report to Congress: Recommendations to Better Leverage Federal Policies and Programs to Prevent and Control Diabetes. Diabetes Care. 2023. PMID: 36701592. doi:10.2337/dc22-1587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。